adenine has been researched along with Myelodysplastic Syndromes in 4 studies
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
Excerpt | Relevance | Reference |
---|---|---|
"Do patients with therapy-related acute myeloid leukemia (t-AML) have a poor prognosis independent of other predictive variables such as cytogenetics or molecular determinants? Limited data exist to answer this question in part because t-AML is often considered together with AML following myelodysplastic syndromes (MDS) in the category of secondary AML." | 1.37 | Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants? ( Feldman, EJ, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Perrard, N | 1 |
Pokeerbux, MR | 1 |
Quesnel, B | 1 |
Duployez, N | 1 |
Fenwarth, L | 1 |
Preudhomme, C | 1 |
Lefèvre, G | 1 |
Baillet, C | 1 |
Launay, D | 1 |
Terriou, L | 1 |
Huls, G | 1 |
Chitu, DA | 1 |
Pabst, T | 1 |
Klein, SK | 1 |
Stussi, G | 1 |
Griskevicius, L | 1 |
Valk, PJM | 1 |
Cloos, J | 1 |
van de Loosdrecht, AA | 1 |
Breems, D | 1 |
van Lammeren-Venema, D | 1 |
van Zeventer, I | 1 |
Boersma, R | 1 |
Jongen-Lavrencic, M | 1 |
Fehr, M | 1 |
Hoogendoorn, M | 1 |
Manz, MG | 1 |
Söhne, M | 1 |
van Marwijk Kooy, R | 1 |
Deeren, D | 1 |
van der Poel, MWM | 1 |
Legdeur, MC | 1 |
Tick, L | 1 |
Chalandon, Y | 1 |
Ammatuna, E | 1 |
Blum, S | 1 |
Löwenberg, B | 1 |
Ossenkoppele, GJ | 1 |
Jain, P | 1 |
Feldman, EJ | 1 |
1 review available for adenine and Myelodysplastic Syndromes
Article | Year |
---|---|
Lenalidomide-induced acute liver failure.
Topics: Adenine; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Hepatitis B, Chronic; Humans; L | 2009 |
1 trial available for adenine and Myelodysplastic Syndromes
Article | Year |
---|---|
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS.
Topics: Adenine; Decitabine; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Netherlands; Piper | 2020 |
2 other studies available for adenine and Myelodysplastic Syndromes
Article | Year |
---|---|
[GATA2 gene mutations: 3 cases].
Topics: Adenine; Adult; Female; GATA2 Transcription Factor; Humans; Immunologic Deficiency Syndromes; Leukem | 2022 |
Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants?
Topics: Adenine; Anthracyclines; Antineoplastic Agents; Biomarkers, Tumor; Cytarabine; Cytogenetics; Female; | 2011 |